Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19

Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf, the ENSEMBLE2 Study Group
doi: https://doi.org/10.1101/2022.01.28.22270043
Karin Hardt
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
An Vandebosch
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Sadoff
2Janssen Vaccines and Prevention, Leiden, The Netherlands
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Le Gars
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla Truyers
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lowson
3Janssen Research and Development, High Wycombe, UK
M.Sc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilse Van Dromme
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Vingerhoets
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Kamphuis
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert Scheper
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Ruiz-Guiñazú
1Janssen Research and Development, Beerse, Belgium
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saul N. Faust
4NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK
F.R.C.P.C.H.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph D. Spinner
5Technical University of Munich, Munich, Germany
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanneke Schuitemaker
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Van Hoof
2Janssen Vaccines and Prevention, Leiden, The Netherlands
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Macaya Douoguih
2Janssen Vaccines and Prevention, Leiden, The Netherlands
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Struyf
1Janssen Research and Development, Beerse, Belgium
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: FStruyf{at}ITS.JNJ.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading
  • Supplementary Appendix[supplements/270043_file03.pdf]
  • CONSORT Checklist[supplements/270043_file04.docx]
Back to top
PreviousNext
Posted January 31, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf, the ENSEMBLE2 Study Group
medRxiv 2022.01.28.22270043; doi: https://doi.org/10.1101/2022.01.28.22270043
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf, the ENSEMBLE2 Study Group
medRxiv 2022.01.28.22270043; doi: https://doi.org/10.1101/2022.01.28.22270043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)